Sage Therapeutics, Inc. (SAGE) financial statements (2022 and earlier)

Company profile

Business Address 215 FIRST STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,7421,8431,9112,0042,100669757
Cash and cash equivalents2944225148991,661184258
Short-term investments1,4481,4211,3971,105438484498
Receivables19244825   
Other undisclosed current assets40342923233029
Total current assets:1,8011,9021,9892,0522,122699785
Noncurrent Assets
Operating lease, right-of-use asset16171920252728
Property, plant and equipment3334778
Restricted cash and investments1111222
Other noncurrent assets4443333
Total noncurrent assets:25252729374042
TOTAL ASSETS:1,8251,9272,0152,0812,159739827
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities78726555595156
Accounts payable10533442
Accrued liabilities67676251554753
Other undisclosed current liabilities7777999
Total current liabilities:85797262676064
Noncurrent Liabilities
Long-term debt and lease obligation11121415192123
Operating lease, liability11121415192123
Liabilities, other than long-term debt000 000
Other liabilities000 000
Other undisclosed noncurrent liabilities   (15)   
Total noncurrent liabilities:11131415202123
Total liabilities:96928677878187
Stockholders' equity
Stockholders' equity attributable to parent1,7291,8361,9302,0032,072658740
Common stock0000000
Treasury stock, value(0)(0)(0)(0)(0)(0)(0)
Additional paid in capital3,2273,2073,1713,1373,1102,6692,645
Accumulated other comprehensive income (loss)(3)(0)(0)(0)012
Accumulated deficit(1,495)(1,371)(1,241)(1,133)(1,037)(2,012)(1,907)
Total stockholders' equity:1,7291,8361,9302,0032,072658740
TOTAL LIABILITIES AND EQUITY:1,8251,9272,0152,0812,159739827

Income statement (P&L) ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues212 1,10921
Gross profit:212 1,10921
Operating expenses(127)(132)(110)(98)(135)(109)(140)
Other undisclosed operating income   2   
Operating income (loss):(125)(131)(108)(97)974(107)(139)
Nonoperating income (expense)(4)00(1)(0)0(0)
Investment income, nonoperating(4)  (1)(0)  
Other nonoperating income (expense)000000(0)
Other undisclosed income from continuing operations before equity method investments, income taxes    11  
Income (loss) from continuing operations before equity method investments, income taxes:(130)(131)(108)(98)984(107)(139)
Other undisclosed income from continuing operations before income taxes16      
Income (loss) before gain (loss) on sale of properties:(114)(131)(108)(98)984(107)(139)
Other undisclosed net income (loss)(11)  2(9)  
Net income (loss):(125)(131)(108)(96)975(107)(139)
Other undisclosed net income attributable to parent 11  13
Net income (loss) available to common stockholders, diluted:(125)(130)(107)(96)975(106)(136)

Comprehensive Income ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net income (loss):(125)(131)(108)(96)975(107)(139)
Other comprehensive income (loss)(2)(0)(0)(1)(1)(1)3
Comprehensive income (loss):(127)(131)(108)(96)974(108)(137)
Other undisclosed comprehensive income, net of tax, attributable to parent 11  13
Comprehensive income (loss), net of tax, attributable to parent:(127)(130)(107)(96)974(106)(134)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: